3 If initial therapy with metformin and lifestyle efforts are not adequate to achieve individualized glycemic targets, the guidelines recommend that patients should progress to dual therapy by adding either another oral agent, basal insulin, or an injectable GLP-1 receptor agonist
As internists, we can prescribe anti-nausea medication and additional treatments Lifestyle disease values (blood sugar, blood pressure, lipids) monitored together For those who were hesitant to start due to fear of injections , Rybelsus is the perfect first step If results are insufficient, we can discuss stepping up to an injectable (Mounjaro or Wegovy) What Is Rybelsus
Systemic Lupus Erythematosus Systemic lupus erythematosus, often simply called lupus, is a chronic inflammatory disease that can affect almost any part of the body, especially the skin, joints, kidneys, heart, lungs, bones, blood, or brain
However, patients and prescribers can expect actual dispensing and availability to providers in the coming weeks. The future of oral GLP-1s in Europe In May, the European Medicines Agency committee responsible for human medicines recommended an extension to the marketing authorisation for Wegovy to include its Wegovy pill